Monday, February 22, 2016 | 9:00 AM - 5:00 PM
Speakers: John F. DiPersio (Washington University School of Medicine), Jonathan D. Glass (Emory University School of Medicine), Edward O. Lanphier (Sangamo BioSciences, Inc.), Jane S. Lebkowski (Asterias Biotherapeutics), Racheli Ofir (Pluristem LTD), Mahendra Rao (Wake Forest University School of Medicine), Thomas Schulz (ViaCyte, Inc.), John D. Sinden (ReNeuron Limited), Katherine Tsokas (Janssen Research & Development)
Advances in gene editing have driven an explosion of pre-clinical cell-based therapies. This event addresses the need to rethink clinical, regulatory, & manufacturing approaches to accelerate the transition of drugs through the clinic.
Monday, February 29, 2016 | 9:00 AM - 5:00 PM
Keynote Speakers: Renier Brentjens (Memorial Sloan Kettering Cancer Center), Jedd Wolchok (Memorial Sloan Kettering Cancer Center)
Speakers: Jane Gross (Emergent Biosolutions, Inc), John Hunter (Compugen Ltd), Jane S. Lebkowski (Asterias Biotherapeutics), Jens-Peter Marschner (Affimed AG), Charles Nicolette (Argos Therapeutics, Inc), Charles L. Sentman (Dartmouth Geisel School of Medicine), David M Spencer (Bellicum Pharmaceuticals), Roland Walter (Fred Hutchinson Cancer Research Center)
Emerging strategies for Cancer Immunotherapy are changing the face of cancer treatment. This symposium will bring together experts in immunotherapy and immunology to discuss emerging approaches, challenges, and opportunities in this evolving field
Tuesday, March 15, 2016 | 8:30 AM - 4:30 PM
Speakers: Premysl Bercik (McMaster University Medical Centre), John F Cryan (University College Cork), Ted Dinan (University College Cork), Emeran Mayer (David Geffen School of Medicine, UCLA), Sarkis Mazmanian (California Institute of Technology), Vassilis Pachnis, MD (The Francis Crick Institute), Robert Yolken (John Hopkins School of Medicine)
The gut microbiome is emerging as an important regulator of brain development, brain health, and disease. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on CNS health.
Tuesday, March 22, 2016 | 12:00 PM - 4:00 PM
Speakers: Wenbiao Gan (NYU Langone Medical Center), Bruce McEwen (Rockefeller University), Eric Nestler (Icahn School of Medicine at Mount Sinai), Amy Robinson (MIT), Bernardo Sabatini (Harvard Medical School), David Sulzer (Columbia University Medical Center)
Mapping neuronal circuitry provides important insight into mammalian health and disease. This symposium will discuss emerging tools and novel findings that address this important goal.
March 30 - April 1, 2016
Keynote Speakers: Richard Gilbertson (Cambridge Cancer Center, University of Cambridge), Craig B. Thompson (Memorial Sloan Kettering Cancer Center)
Speakers: Scott Armstrong (Memorial Sloan Kettering Cancer Center), Eric Bouffet (The Hospital for Sick Children, Toronto), Stefan Burdach (Technical University of Munich, Germany), Michael Dyer (St. Jude Children's Research Hospital, Howard Hughes Medical Institute), Nancy Goodman (Kids V Cancer), Lee J. Helman (National Cancer Institute, National Institutes of Health), Nada Jabado (McGill University), Katherine A. Janeway (Dana-Farber Cancer Center, Harvard Medical School), Michael Jensen (Seattle Children's Hospital), Javed Khan (National Cancer Institute, National Institutes of Health), Andrew Kung (Columbia University Medical Center), A. Thomas Look (Dana-Farber Cancer Center, Harvard University), David C. Lyden (Weill Cornell Medical College), Elizabeth Maher (University of Texas Southwestern Medical Center), David Malkin (The Hospital for Sick Children), John Maris (The Children's Hospital of Philadelphia and the University of Pennsylvania), Yael Mossé (The Children’s Hospital of Philadelphia), Kathy Pritchard-Jones (Great Ormond Street Hospital for Children NHS Foundation Trust and University College London), Charles W.M. Roberts (St. Jude Children's Research Hospital), Michel Sadelain (Memorial Sloan Kettering Cancer Center), Paul M. Sondel (University of Wisconsin School of Medicine and Public Health), Poul H. Sorensen (University of British Columbia), Kimberly Stegmaier (Dana-Farber Cancer Institute), Michael D. Taylor (The Hospital for Sick Children, University of Toronto), Matthew Vander Heiden (The Koch Institute, Massachusetts Institute of Technology), Robert Wechsler-Reya (Sanford Burnham Prebys Institute of Medical Discovery)
Discover the latest on pediatric cancers from leading experts, including etiological differences between pediatric and adult cancers, epigenetics, mechanisms of metastasis and disease recurrence, risk factors, diagnostics, and novel treatment approaches.
Tuesday, April 26, 2016 | 9:00 AM - 5:00 PM
Speakers: Dax Fu (John Hopkins School of Medicine), Kathleen M. Giacomini (University of California, San Francisco), Matthias A. Hediger (University of Bern), Avner Schlessinger (Icahn School of Medicine at Mount Sinai), Giulio Superti-Furga (Austrian Academy of Sciences), Ming Zhou (Baylor College of Medicine)
Solute Carrier Proteins are an untapped resource for drug discovery. This event will discuss breakthroughs in structural biology, cell engineering and metabolomics that hold the promise of "unlocking" this gene family.
May 18 - 20, 2016
Keynote Speakers: Nora D. Volkow (National Institute on Drug Abuse, U.S. National Institutes of Health), George F. Koob (National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health)
Speakers: Michael R. Bruchas (Washington University School of Medicine), Meaghan Creed (University of Geneva), Ronald G. Crystal (Weill Cornell Medical College), Thomas Eissenberg (Virginia Commonwealth University), Barry J. Everitt (University of Cambridge), Diana Fishbein (Pennsylvania State University), Yasmin Hurd (Icahn School of Medicine at Mount Sinai Hospital), Thomas Kash (University of North Carolina School of Medicine), Honorable Patrick J. Kennedy (Former U.S. Representative, Rhode Island; One Mind for Research; and Kennedy Forum), Mark A.R. Kleiman (New York University, Marron Institute of Urban Management), David M. Lovinger (National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health), A. Thomas McLellan (University of Pennsylvania), P. Read Montague (Virginia Polytechnic Institute and State University), Eric J. Nestler (Icahn School of Medicine at Mount Sinai Hospital), Susan F. Tapert (University of California San Diego), Susan R.B. Weiss (National Institute on Drug Abuse, U.S. National Institutes of Health)
Discover from leading experts, including NIAAA and NIDA directors, the latest on neurobiology of addiction; susceptibility of the teen brain; new treatment strategies; and social, economic, political, and legislative aspects of this disease.
For multimedia from recent Academy webinars, please view the Academy's eBriefings catalog.